Evaluation of Peripartum Blood Loss and Postpartum Anaemia in Macrosomia & Gemini
NCT ID: NCT06201910
Last Updated: 2025-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
575 participants
OBSERVATIONAL
2023-10-01
2025-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Impact of Implementing a Patient Blood Management Protocol on the Transfusion Rate in Delivery Hemorrhage
NCT06916832
Serum Hepcidin in Pregnant Women and the Association With Pregnancy Outcome
NCT03792464
The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant
NCT04101461
Iron Deficiency Anemia in Twin Pregnancies
NCT04975074
Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
NCT04812821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Treatment of iron deficiency anaemia is essential because data show that iron deficiency anaemia is associated with increased maternal morbidity, fetal morbidity and mortality. Studies show a separate risk of bleeding in pregnant women due to increased uterine prolapse, for example in twin pregnancies or macrosomic singletons. At present, the prepartum anaemia management of patients, the influence of anaemia and the administration of foreign blood concentrates are insufficiently studied, which the investigators intend to investigate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controll
Pregnant women without uterine dilation due to a twin pregnancy or a macrosomic singleton
Observation of Blood loss
Retrospetive observation of bloodloss and RBC transfusions.
Gemini
Pregnant women with uterine dilation due to a twin pregnancy
Observation of Blood loss
Retrospetive observation of bloodloss and RBC transfusions.
Makrosome
Pregnant women with uterine dilation due to a macrosomic singleton
Observation of Blood loss
Retrospetive observation of bloodloss and RBC transfusions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation of Blood loss
Retrospetive observation of bloodloss and RBC transfusions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Goethe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Armin N. Flinspach
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany
Goethe University
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-1405
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.